77
Views
0
CrossRef citations to date
0
Altmetric
Perspectives

C-type lectin receptors and RIG-I-like receptors: new points on the oncogenomics map

&
Pages 39-53 | Published online: 24 Feb 2012

References

  • KawaiTAkiraSToll-like receptors and their crosstalk with other innate receptors in infection and immunityImmunity201134563765021616434
  • ElinavEStrowigTHenao-MejiaJFlavellRARegulation of the antimicrobial response by NLR proteinsImmunity201134566567921616436
  • OsorioFReisESousaCMyeloid C-type lectin receptors in pathogen recognition and host defenseImmunity201134565166421616435
  • LooYMGaleMJrImmune signaling by RIG-I-like receptorsImmunity201134568069221616437
  • LambaVLambaJYasudaKHepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expressionJ Pharmacol Exp Ther2003307390692214551287
  • TierneyMJMedcalfRLPlasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAsJ Biol Chem200127617136751368411278713
  • ThomasKHMeynPSuttorpNSingle nucleotide polymorphism in 5′-flanking region reduces transcription of surfactant protein B gene in H441 cellsAm J Physiol Lung Cell Mol Physiol20062913L386L39016500948
  • ZysowBRLindahlGEWadeDPKnightBLLawnRMC/T polymorphism in the 5′ untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translationArterioscler Thromb Vasc Biol199515158647749816
  • BellJKMullenGELeiferCAMazzoniADaviesDRSegalDMLeucine-rich repeats and pathogen recognition in toll-like receptorsTrends Immunol2003241052853314552836
  • JohnsonCMLyleEAOmuetiKOCutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosyJ Immunol2007178127520752417548585
  • ChangAHParsonnetJRole of bacteria in oncogenesisClin Microbiol Rev201023483785720930075
  • de MartelCFranceschiSInfections and cancer: established associations and new hypothesesCrit Rev Oncol Hematol200970318319418805702
  • HattoriTKonnoSHizawaNGenetic variants in the mannose receptor gene (MRC1) are associated with asthma in two independent populationsImmunogenetics20096111–1273173819902202
  • AlterAde LéséleucLVan ThucNGenetic and functional analysis of common MRC1 exon 7 polymorphisms in leprosy susceptibilityHum Genet2010127333734820035344
  • HattoriTKonnoSTakahashiAGenetic variants in mannose receptor gene (MRC1) confer susceptibility to increased risk of sarcoidosisBMC Med Genet20101115121029423
  • XuYFLiuWLDongJQSequencing of DC-SIGN promoter indicates an association between promoter variation and risk of nasopharyngeal carcinoma in cantoneseBMC Med Genet20101116121067616
  • SakuntabhaiATurbpaiboonCCasadémontIA variant in the CD209 promoter is associated with severity of dengue diseaseNat Genet200537550751315838506
  • WangLChenRFLiuJWDC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentationPLoS Negl Trop Dis201151e93421245921
  • BarreiroLBNeyrollesOBabbCLPromoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosisPLoS Med200632e2016379498
  • VannbergFOChapmanSJKhorCCCD209 genetic polymorphism and tuberculosis diseasePLoS One200831e138818167547
  • SelvarajPAlagarasuKSwaminathanSHarishankarMNarendranGCD209 gene polymorphisms in South Indian HIV and HIV-TB patientsInfect Genet Evol20099225626219126442
  • NúñezCRuedaBMartínezAA functional variant in the CD209 promoter is associated with DQ2-negative celiac disease in the Spanish populationWorld J Gastroenterol200612274397440016865785
  • NúñezCOliverJMendozaJLCD209 in inflammatory bowel disease: a case-control study in the Spanish populationBMC Med Genet200787518070336
  • MezgerMSteffensMSemmlerCInvestigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantationClin Microbiol Infect200814322823418076668
  • ZhengRZhouYQinLRelationship between polymorphism of DC-SIGN (CD209) gene and the susceptibility to pulmonary tuberculosis in an eastern Chinese populationHum Immunol201172218318621081145
  • KoizumiYKageyamaSFujiyamaYRANTES -28G delays and DC-SIGN – 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacsAIDS Res Hum Retroviruses200723571371917530998
  • KashimaSRodriguesESAzevedoRDC-SIGN (CD209) gene promoter polymorphisms in a Brazilian population and their association with human T-cell lymphotropic virus type 1 infectionJ Gen Virol200990Pt 492793419264667
  • RyanEJDringMRyanCMVariant in CD209 promoter is associated with severity of liver disease in chronic hepatitis C virus infectionHum Immunol201071882983220470843
  • ChanKYXuMSChingJCCD209 (DC-SIGN) -336 A > G promoter polymorphism and severe acute respiratory syndrome in Hong Kong ChineseHum Immunol201071770270720359516
  • ChanKYXuMSChingJCAssociation of a single nucleotide polymorphism in the CD209 (DC-SIGN) promoter with SARS severityHong Kong Med J2010165 Suppl 4374220864747
  • PlantingaTSFransenJTakahashiNFunctional consequences of DECTIN-1 early stop codon polymorphism Y238X in rheumatoid arthritisArthritis Res Ther2010121R2620158887
  • CunhaCDi IanniMBozzaSDectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunityBlood2010116245394540220807886
  • ChaiLYde BoerMGvan der VeldenWJThe Y238X stop codon polymorphism in the human β-glucan receptor Dectin-1 and susceptibility to invasive aspergillosisJ Infect Dis2011203573674321242599
  • PlantingaTSvan der VeldenWJFerwerdaBEarly stop polymorphism in human Dectin-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipientsClin Infect Dis200949572473219614557
  • PlantingaTSHamzaOJWillmentJAGenetic variation of innate immune genes in HIV-infected african patients with or without oropharyngeal candidiasisJ Acquir Immune Defic Syndr2010551879420577092
  • PothlichetJBurteyAKubarenkoAVStudy of human RIG-I polymorphisms identifies two variants with an opposite impact on the antiviral immune responsePLoS One2009410e758219859543
  • ShigemotoTKageyamaMHiraiRZhengJYoneyamaMFujitaTIdentification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetesJ Biol Chem200928420133481335419324880
  • OvsyannikovaIGDhimanNHaralambievaIHRubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genesHum Genet2010127220722119902255
  • OvsyannikovaIGHaralambievaIHDhimanNPolymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccinationJ Infect Dis2010201220721320001730
  • HuJNistal-VillánEVohoAA common polymorphism in the caspase recruitment domain of RIG-I modifies the innate immune response of human dendritic cellsJ Immunol2010185142443220511549
  • ShuXJiJLiXSundquistJSundquistKHemminkiKCancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in SwedenDiabet Med201027779179720636960
  • ZendehdelKNyrénOOstensonCGAdamiHOEkbomAYeWCancer incidence in patients with type 1 diabetes mellitus: a population- based cohort study in SwedenJ Natl Cancer Inst200395231797180014652242
  • SwerdlowAJLaingSPQiaoZCancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort studyBr J Cancer200592112070207515886700
  • HjalgrimHFrischMEkbomAKyvikKOMelbyeMGreenACancer and diabetes – a follow-up study of two population-based cohorts of diabetic patientsJ Intern Med1997241647147510497622
  • BahmanyarSMontgomerySMHillertJEkbomAOlssonTCancer risk among patients with multiple sclerosis and their parentsNeurology200972131170117719332695
  • NielsenNMRostgaardKRasmussenSCancer risk among patients with multiple sclerosis: a population-based register studyInt J Cancer2006118497998416152598
  • SumelahtiMLPukkalaEHakamaMCancer incidence in multiple sclerosis: a 35-year follow-upNeuroepidemiology200423522422715316248
  • MidgardRGlattreEGrønningMRiiseTEdlandANylandHMultiple sclerosis and cancer in Norway. A retrospective cohort studyActa Neurol Scand19969364114158836302
  • FoisAFWottonCJYeatesDTurnerMRGoldacreMJCancer in patients with motor neuron disease, multiple sclerosis and Parkinson’s disease: record linkage studiesJ Neurol Neurosurg Psychiatry201081221522119726405
  • PothlichetJNiewoldTBVitourDSolhonneBCrowMKSi-TaharMA loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patientsEMBO Mol Med20113314215221268286
  • LiuXJiaoYWenXPossible association of VISA gene polymorphisms with susceptibility to systemic lupus erythematosus in Chinese populationMol Biol Rep20113874583458821127988